Won W Shon

Dermatopathologist and Bone and Soft Tissue Pathologist @CedarsSinai

[Satya Nadella @satyanadella]

We’ve trained a multimodal AI model to turn routine pathology slides into spatial proteomics, with the potential to reduce time and cost while expanding access to cancer care.

[Christine J. Ko, MD @ChristineJKoMD]

Dr. Wolfgang Weyers: Every melanoma is unique. 'Any classification is artificial,' said Lamarck. Dive into the intricate realities of melanoma diagnosis #MelanomaAwareness #CancerResearch #dermatology #pathology #dermpath full episode https://t.co/tmcbxulUOj

[Mayo Clinic Pathology @MayoClinicPath]

Celebrating 120 years of the frozen section
(1905-2025) at Mayo Clinic Rochester @joaquingarciamd @GaryKeeneyMD @JenniferBoland7 @rondell_graham @docsaadiya

[Omid Hamid MD @OmidHamidMD]

Two decades here at The Angeles Clinic with @MarkFariesMD fighting #Melanoma at @CedarsSinai , @PMCSJH
#MelanomaAwarenessMonth no different. Real breakthroughs together with more #worktodo #clinicaltrials
[email protected]

[Christine J. Ko, MD @ChristineJKoMD]

Such gorgeous figures, @RACARR51 ! a beautiful paper!! https://t.co/5PkRYTLECZ #dermpath #pathology #Cancer

[Arnaud de la Fouchardiere MD, PhD @melanopath]

The hype is strong with this one. #streetart #dermpath

[Professor Richard Scolyer AO @ProfRAScolyer]

I am very proud to be part of the amazing team of researchers, scientists and clinicians who are all co-authors of the important research publication just released in Nature Medicine. The paper documents changes in my brain tumour & blood before and after I received neoadjuvant systemic combination immunotherapy treatment, which occurred in 2023.

Everyone involved, including lead authors Georgina Long and Helen Rizos, used their expertise, knowledge and creative intellect to generate this important data just released.

Whilst the paper deals with the data from just one patient (me), ultimately a clinical trial of a large group of patients needs to be conducted to determine whether or not neoadjuvant (pretreatment) combination immunotherapy is clinically effective in (a subgroup of) brain cancer patients. I hope such a trial begins in the not too distant future.

Congratulations to everyone who has contributed to this research. What a fantastic achievement!

But this is only the beginning & much more research is required to improve treatment and outcomes and ultimately save lives.

@SydneyLHD
@NthSydHealth
@Sydney_Uni
@COBLH
#glioblastoma

[American Journal of Dermatopathology @AJDP_Journal]

#WhatsNewInDermpath

“Pathway leap”: a new molecular phenomenon to consider in the pathogenesis of melanocytic tumors
- melanocytic tumors of a specific pathway may “leap” to another pathway through a mutational process.

Full article link: https://t.co/1zlGMQHYOL

[Arnaud de la Fouchardiere MD, PhD @melanopath]

@AJDP_Journal @HoustonArsenal @CakePath @Dermpathl @dermpathX @MarcelaSaebL @RACARR51 @pembeoltulu @vgprieto14 @david_terrano I need to read this.

[Johns Hopkins Pathology @JHUPath]

Tenosynovitis with psammomatous calcifications: Series of 18 cases and review of the literature emphasizing a common source of expert consultation and updated differential diagnosis

By @JMcMahonG and outstanding Hopkins trainees and colleagues

https://t.co/oa3XVYt8Ik

[Justin Moyers @jtmoyers]

Saturday morning with a visit from @DrSapnaPatel presenting on adjuvant and neoadjuvant and adjuvant melanoma therapies at the @CSCancerCenter melanoma retreat!

@angelesclinic

[Jason L. Hornick, M.D., Ph.D. @JLHornick]

Dear colleagues and friends, as I am sure all of you know, my mentor, colleague, and friend Dr. Chris Fletcher passed away last month. Several of his friends are initiating a fundraising activity through the USCAP Foundation to support an annual award in his name at the USCAP meeting to honor Dr. Fletcher's many outstanding qualities, including excellence in surgical pathology, education, mentorship, leadership, and advocacy. Please consider donating to this fund, as well as passing this on to your colleagues. Thank you so much for your consideration.
@BWHPath @TheUSCAP

https://t.co/6oLVupZTBk

[Dr. Mahul Amin @DrMahul]

Advances in Anatomic Pathology is a top 10 pathology journal by impact factor and top 2 journal read by Anatomic and Molecular Pathology. Honored to be editor in chief for 24 years - thank you readers and contributors! #PathTwitter #pathology

[Konstantinos LinosMD @KonstantinosLin]

Our new work. Superficial Wnt-activated melanocytic nevi/melanocytomas with a junctional component. American Journal of Dermatopathology
#pathology #dermatology #melanocytic

[Arnaud de la Fouchardiere MD, PhD @melanopath]

Describing new gene fusion LMNA::MST1R involved in Spitz lineage tumours. MST1R (as a 1337 native I pronounce it Mr) is an analog of MET.
Free access for 50 days curtesy of @Elsevier
https://t.co/8kPVs7Uqm2
#dermtwitter #dermpath #PathTwitter

[American Journal of Dermatopathology @AJDP_Journal]

#ThrowbackThursday
Nevic Mitoses: A Review of 1041 Cases

This study in 2013 concluded that mitotic figures, even multiple ones, do not preclude benignity in a variety of melanocytic nevi.
https://t.co/eu0vuBRxIT
What are your thoughts?

[American Journal of Dermatopathology @AJDP_Journal]

#ThrowbackThursday
In 2000, Dr. Phillip Leboit @UCSFPath wrote this editorial "No Worlds Left to Conquer?"
He raised some pertinent questions and suggested areas of potential research
https://t.co/U9wtwNs7MM
@IntSocDermpath @PIorfino @Dermpathl @dermpathX @BethRubenMD @forthejon

[American Journal of Dermatopathology @AJDP_Journal]

Although many cases and small series of toxic erythema of chemotherapy (TEC) have been described, the full spectrum of findings is not well understood.

This CME article will help understand the spectrum of clinical and histopathological findings
https://t.co/cmY90lp4wf

[Peter Sadow, MD, PhD @PathDocBoston]

Interesting about all the talk of soaring health care costs while reimbursements to #pathologists have declined >25% over the past 25 years. Maybe drug companies should stop advertising direct to consumer since consumers cannot buy over-the-counter? Just a thought...Step 1

[David West @davidwest_irl]

39% of surveyed lab directors believe LDT regulation will harm patient care.

Only 12% believe the regulation will make lab testing more accurate and safer.

Who is behind this regulation?